openPR Logo
Press release

Renal Disease Global Market 2018-2023: Key Players - Abbott (US), Amgen Inc. (US), Baxter (US), Bristol-Myers Squibb Company (US), Keryx Biopharmaceuticals, Inc. (US), NephroGenex, Inc. (US)

06-22-2018 05:09 PM CET | Health & Medicine

Press release from: Market Research Future

/ PR Agency: Market Research Future
Renal Disease Global Market 2018-2023: Key Players - Abbott

Market Scenario:
Renal disease also known as kidney diseases that affects the functioning of kidneys. According to National Kidney Foundation, Inc.,10% of world’s population is suffering from chronic kidney diseases. Global Renal disease Market is growing moderately. The growing prevalence of renal diseases is leading the market growth. Increasing R&D activities and clinical trials are major driving forces of the market. Increasing acquaintance and awareness among the patients, growing healthcare sector, government initiatives and new product launches are key factors for the global renal disease market.
The Global Renal disease market is growing at the CAGR of ~6.3% during the forecast period and expected to reach US$ 14291.2 million by 2023.
Reqeust for Reports Sample @ https://www.marketresearchfuture.com/sample_request/3167

Study objectives of Global Renal disease Market:
• To provide detailed analysis of the Global Renal disease market structure with historical and forecasted revenue for the next 7 years of the various segments and sub-segments of the Renal disease Market
• To provide insights about the key drivers, restraints, opportunities and challenges that affecting the growth of the Renal disease market
• To provide analysis of the market with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
• To provide detail analysis of the market that segmented on the basis of type, by diagnosis, by treatment, and its sub-segments.
• To provide detail analysis of global renal disease market mainly based on Value chain analysis, Porter’s five forces, Price analysis, and Supply Chain analysis etc.
• To provide detail country level analysis of the market with respect to the current market size and future prospective
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global Renal disease Market
• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the renal diseases market

Key Players for Global Renal disease Market:
Some of the key players in this market are: Abbott (US), Amgen Inc. (US), Baxter (US), Bristol-Myers Squibb Company (US), Keryx Biopharmaceuticals, Inc. (US), NephroGenex, Inc. (US), Novartis AG (Switzerland), Pfizer Inc.(US), Sanofi (France), Shire Pharmaceuticals Limited (Republic of Ireland), and others.
Segments:
Global Renal disease Market has been segmented on the basis of type which comprise acute kidney problems (Prerenal, Postrenal, Renal), Chronic kidney diseases, and others. On the basis of diagnosis, it segmented into Blood Tests (Serum Creatinine, Glomerular Filtration Rate(GFR), Blood Urea Nitrogen (BUN), fasting blood glucose test), Urine test (Urinalysis, Protein urine test, Microalbuminuria test, Creatinine Clearance test), Imaging test (Ultrasound, CT Scan ), Removing a sample of kidney tissue for testing. On the basis of treatment, it segmented into medication (High blood pressure medications, Medications to lower cholesterol levels, Medications to treat anemia, Medications to relieve swelling, Medications to protect your bones), Dialysis (Hemodialysis, Peritoneal dialysis), kidney transplant (Deceased-donor kidney transplant, Living-donor kidney transplant, Pre-emptive kidney transplant ), surgery (Nephrectomy and radical nephrectomy, nephron-sparing surgery (NSS), nephrolithotripsy , Extracorporeal shock wave lithotripsy (ESWL), and others), diet and others.
Report with Discount Available @ https://www.marketresearchfuture.com/check-discount/3167


1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Mega Trends
4.5 Macroeconomic Indicators
5. Market Factor Analysis
5.1 Value Chain Analysis
5.2 Porters Five Forces
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
5.5 Investment Opportunity Analysis

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Renal Disease Global Market 2018-2023: Key Players - Abbott (US), Amgen Inc. (US), Baxter (US), Bristol-Myers Squibb Company (US), Keryx Biopharmaceuticals, Inc. (US), NephroGenex, Inc. (US) here

News-ID: 1094903 • Views:

More Releases from Market Research Future

9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through 2035
9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years. Market Overview and Size The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends. Get Sample @ https://www.marketresearchfuture.com/sample_request/41217 Market Size and Growth The global washable
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR by 2032
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview: The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical

All 5 Releases


More Releases for Renal

Advancements in Renal Dialysis Equipment Trend: A Crucial Influence on the Renal …
What market dynamics are playing a key role in accelerating the growth of the renal dialysis equipment market? The escalating incidence of chronic kidney disease is projected to boost the expansion of the renal dialysis equipment market. Chronic kidney disease, a term that describes the slow and progressive decline of kidney function, can ultimately result in kidney failure and other severe health conditions. This disease is linked with several risk factors
Renal Osteodystrophy Market: An In-Depth Analysis
The Renal Osteodystrophy Market was valued at approximately USD 2.4 billion in 2023 and is projected to reach around USD 7.1 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2024 to 2032. Renal Osteodystrophy Market Overview The Renal Osteodystrophy Market is experiencing significant growth, driven by the increasing prevalence of chronic kidney disease (CKD) and the associated bone disorders. Advancements in diagnostic techniques have enhanced early
Shaping the Renal Dialysis Equipment Market in 2025: Advancements in Renal Dialy …
How Big Is the Renal Dialysis Equipment Market Expected to Be, and What Will Its Growth Rate Be? In recent years, the renal dialysis equipment market has seen robust growth. It's projected to increase from $19.52 billion in 2024 to $20.92 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.2%. Factors contributing to growth in the historic period include comprehensive training and support programs, substantial research and development
Transforming the Veterinary Renal Disease Market in 2025: Increasing Pet Ownersh …
"What Is the Expected Size and Growth Rate of the Veterinary Renal Disease Market? The market size for veterinary kidney diseases has seen profound growth recently. It is set to expand from $15.5 billion in 2024 to $16.63 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. Several factors contributed to this growth during the historical period, including heightened initiatives to increase disease awareness, a shift in
Renal Cancer Pipeline Outlook Report 2024
DelveInsight's, "Renal Cancer Pipeline Insight 2024" report provides comprehensive insights about 75+ Renal Cancer companies and 80+ pipeline drugs in the Renal Cancer pipeline landscape. It covers the Renal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Renal Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways
Renal Biomarker Market to register a CAGR of 7.0% by 2026: Rising Prevalence of …
Future Market Insights delivers key insights on the global renal biomarker market in a new report titled “Renal Biomarker Market: Global Industry Analysis and Opportunity Assessment, 2016–2026.” In terms of revenue, the global renal biomarker market is projected to register a healthy CAGR of 7.0% over the forecast period. In this report, Future Market Insights throws light on the various factors and trends impacting market growth over the forecast period